Budget Impact on the Use of Pegfilgrastim to Reduce the Febrile Neutropenia During Chemotherapy for Breast Cancer with Moderate Risk Compared to a Standard Therapy
Value Health. 2014 Nov;17(7):A623.
doi: 10.1016/j.jval.2014.08.2212.
Epub 2014 Oct 26.